Molecular characterization of Hb S(C) β‐thalassemia in American blacks

J. M. Gonzalez‐Redondo, Abdullah Kutlar, Ferdane Kutlar, V. C. McKie, K. M. McKie, E. Baysal, T. H.J. Huisman

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

An extension of previous reports describing the molecular defects and hematological abnormalities in black patients with Hb S(C) β‐thalassemia living in the Southeastern United States is presented. As many as 58 patients with Hb S‐β+‐thalassemia, 16 with Hb C‐β+‐thalassemia and 12 with Hb S‐β°‐thalassemia have been studied. Patients with Hb S(C) β+‐thalassemia type 2 (high Hb A values) were most common; the thalassemia was due to mutations in the promoter of the β‐globin gene [−88 (C → T) and −29 (A → G)] or at the polyadenylation signal (T → C). Two patients with lower Hb A values (type 1) carried a mutation in the first intron of the β‐globin gene (IVS‐1‐5: G → T). The simultaneous presence of an α‐thalassemia −2( −αl) resulted in some modifications of the hematological parameters, but had a minimal effect on the clinical condition. Patients with Hb S‐β°‐thalassemia had lower hemoglobin values, lower number of red blood cells, and lower MCHC values and suffered more frequently from complications than the patients with Hb S‐β+ ‐thalassemia. A total of 17 different β‐thalassemia mutations were observed in 128 chromosomes; two mild β+ ‐thalassemia mutations [−88(C → T) and −29(A → G)] account for more than 80% of the thalassemic chromosomes.

Original languageEnglish (US)
Pages (from-to)9-14
Number of pages6
JournalAmerican Journal of Hematology
Volume38
Issue number1
DOIs
StatePublished - Jan 1 1991

Fingerprint

Thalassemia
Mutation
Globins
Chromosomes
Southeastern United States
Polyadenylation
Introns
Genes
Hemoglobins
Erythrocytes

Keywords

  • Hb S(C) β‐thalassemia
  • molecular characterization of thalassemias

ASJC Scopus subject areas

  • Hematology

Cite this

Gonzalez‐Redondo, J. M., Kutlar, A., Kutlar, F., McKie, V. C., McKie, K. M., Baysal, E., & Huisman, T. H. J. (1991). Molecular characterization of Hb S(C) β‐thalassemia in American blacks. American Journal of Hematology, 38(1), 9-14. https://doi.org/10.1002/ajh.2830380103

Molecular characterization of Hb S(C) β‐thalassemia in American blacks. / Gonzalez‐Redondo, J. M.; Kutlar, Abdullah; Kutlar, Ferdane; McKie, V. C.; McKie, K. M.; Baysal, E.; Huisman, T. H.J.

In: American Journal of Hematology, Vol. 38, No. 1, 01.01.1991, p. 9-14.

Research output: Contribution to journalArticle

Gonzalez‐Redondo, JM, Kutlar, A, Kutlar, F, McKie, VC, McKie, KM, Baysal, E & Huisman, THJ 1991, 'Molecular characterization of Hb S(C) β‐thalassemia in American blacks', American Journal of Hematology, vol. 38, no. 1, pp. 9-14. https://doi.org/10.1002/ajh.2830380103
Gonzalez‐Redondo, J. M. ; Kutlar, Abdullah ; Kutlar, Ferdane ; McKie, V. C. ; McKie, K. M. ; Baysal, E. ; Huisman, T. H.J. / Molecular characterization of Hb S(C) β‐thalassemia in American blacks. In: American Journal of Hematology. 1991 ; Vol. 38, No. 1. pp. 9-14.
@article{20b03d61279a4beea21aedadd500d63c,
title = "Molecular characterization of Hb S(C) β‐thalassemia in American blacks",
abstract = "An extension of previous reports describing the molecular defects and hematological abnormalities in black patients with Hb S(C) β‐thalassemia living in the Southeastern United States is presented. As many as 58 patients with Hb S‐β+‐thalassemia, 16 with Hb C‐β+‐thalassemia and 12 with Hb S‐β°‐thalassemia have been studied. Patients with Hb S(C) β+‐thalassemia type 2 (high Hb A values) were most common; the thalassemia was due to mutations in the promoter of the β‐globin gene [−88 (C → T) and −29 (A → G)] or at the polyadenylation signal (T → C). Two patients with lower Hb A values (type 1) carried a mutation in the first intron of the β‐globin gene (IVS‐1‐5: G → T). The simultaneous presence of an α‐thalassemia −2( −αl) resulted in some modifications of the hematological parameters, but had a minimal effect on the clinical condition. Patients with Hb S‐β°‐thalassemia had lower hemoglobin values, lower number of red blood cells, and lower MCHC values and suffered more frequently from complications than the patients with Hb S‐β+ ‐thalassemia. A total of 17 different β‐thalassemia mutations were observed in 128 chromosomes; two mild β+ ‐thalassemia mutations [−88(C → T) and −29(A → G)] account for more than 80{\%} of the thalassemic chromosomes.",
keywords = "Hb S(C) β‐thalassemia, molecular characterization of thalassemias",
author = "Gonzalez‐Redondo, {J. M.} and Abdullah Kutlar and Ferdane Kutlar and McKie, {V. C.} and McKie, {K. M.} and E. Baysal and Huisman, {T. H.J.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1002/ajh.2830380103",
language = "English (US)",
volume = "38",
pages = "9--14",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Molecular characterization of Hb S(C) β‐thalassemia in American blacks

AU - Gonzalez‐Redondo, J. M.

AU - Kutlar, Abdullah

AU - Kutlar, Ferdane

AU - McKie, V. C.

AU - McKie, K. M.

AU - Baysal, E.

AU - Huisman, T. H.J.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - An extension of previous reports describing the molecular defects and hematological abnormalities in black patients with Hb S(C) β‐thalassemia living in the Southeastern United States is presented. As many as 58 patients with Hb S‐β+‐thalassemia, 16 with Hb C‐β+‐thalassemia and 12 with Hb S‐β°‐thalassemia have been studied. Patients with Hb S(C) β+‐thalassemia type 2 (high Hb A values) were most common; the thalassemia was due to mutations in the promoter of the β‐globin gene [−88 (C → T) and −29 (A → G)] or at the polyadenylation signal (T → C). Two patients with lower Hb A values (type 1) carried a mutation in the first intron of the β‐globin gene (IVS‐1‐5: G → T). The simultaneous presence of an α‐thalassemia −2( −αl) resulted in some modifications of the hematological parameters, but had a minimal effect on the clinical condition. Patients with Hb S‐β°‐thalassemia had lower hemoglobin values, lower number of red blood cells, and lower MCHC values and suffered more frequently from complications than the patients with Hb S‐β+ ‐thalassemia. A total of 17 different β‐thalassemia mutations were observed in 128 chromosomes; two mild β+ ‐thalassemia mutations [−88(C → T) and −29(A → G)] account for more than 80% of the thalassemic chromosomes.

AB - An extension of previous reports describing the molecular defects and hematological abnormalities in black patients with Hb S(C) β‐thalassemia living in the Southeastern United States is presented. As many as 58 patients with Hb S‐β+‐thalassemia, 16 with Hb C‐β+‐thalassemia and 12 with Hb S‐β°‐thalassemia have been studied. Patients with Hb S(C) β+‐thalassemia type 2 (high Hb A values) were most common; the thalassemia was due to mutations in the promoter of the β‐globin gene [−88 (C → T) and −29 (A → G)] or at the polyadenylation signal (T → C). Two patients with lower Hb A values (type 1) carried a mutation in the first intron of the β‐globin gene (IVS‐1‐5: G → T). The simultaneous presence of an α‐thalassemia −2( −αl) resulted in some modifications of the hematological parameters, but had a minimal effect on the clinical condition. Patients with Hb S‐β°‐thalassemia had lower hemoglobin values, lower number of red blood cells, and lower MCHC values and suffered more frequently from complications than the patients with Hb S‐β+ ‐thalassemia. A total of 17 different β‐thalassemia mutations were observed in 128 chromosomes; two mild β+ ‐thalassemia mutations [−88(C → T) and −29(A → G)] account for more than 80% of the thalassemic chromosomes.

KW - Hb S(C) β‐thalassemia

KW - molecular characterization of thalassemias

UR - http://www.scopus.com/inward/record.url?scp=0025838154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025838154&partnerID=8YFLogxK

U2 - 10.1002/ajh.2830380103

DO - 10.1002/ajh.2830380103

M3 - Article

C2 - 1897518

AN - SCOPUS:0025838154

VL - 38

SP - 9

EP - 14

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -